196 related articles for article (PubMed ID: 35093095)
21. Hyperforin regulates renal fibrosis via targeting the PI3K-AKT/ICAM1 axis.
Yang S; Zhong S; Deng Z; Xie T; Yin G; Wang L; Liu J; Yang J; Long Z; Jiang X; Tan J
Cell Signal; 2023 Aug; 108():110691. PubMed ID: 37116554
[TBL] [Abstract][Full Text] [Related]
22. TGFβ promotes breast cancer stem cell self-renewal through an ILEI/LIFR signaling axis.
Woosley AN; Dalton AC; Hussey GS; Howley BV; Mohanty BK; Grelet S; Dincman T; Bloos S; Olsen SK; Howe PH
Oncogene; 2019 May; 38(20):3794-3811. PubMed ID: 30692635
[TBL] [Abstract][Full Text] [Related]
23. Forsythiaside A suppresses renal fibrosis and partial epithelial-mesenchymal transition by targeting THBS1 through the PI3K/AKT signaling pathway.
Tuoheti K; Bai X; Yang L; Wang X; Cao Y; Yisha Z; Guo L; Zhan S; Wu Z; Liu T
Int Immunopharmacol; 2024 Mar; 129():111650. PubMed ID: 38342062
[TBL] [Abstract][Full Text] [Related]
24. Protective effects of GPR120 agonist-programmed macrophages on renal interstitial fibrosis in unilateral ureteral obstruction (UUO) rats.
Wang L; Ren X; Tian XF; Cheng XL; Zhao YY; Li QY; Duan ZY; Tian LF; Chen Z; Lu JM; Liang XY; Zhao YF; Fu RG
Biomed Pharmacother; 2019 Sep; 117():109172. PubMed ID: 31261028
[TBL] [Abstract][Full Text] [Related]
25. Akt2 is involved in loss of epithelial cells and renal fibrosis following unilateral ureteral obstruction.
Lan A; Zhang J; Xiao Z; Peng X; Qi Y; Du J
PLoS One; 2014; 9(8):e105451. PubMed ID: 25148525
[TBL] [Abstract][Full Text] [Related]
26. Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis.
Li Z; Liu X; Wang B; Nie Y; Wen J; Wang Q; Gu C
Nephrology (Carlton); 2017 Aug; 22(8):589-597. PubMed ID: 27245114
[TBL] [Abstract][Full Text] [Related]
27. CUX1 promotes epithelial-mesenchymal transition (EMT) in renal fibrosis of UUO model by targeting MMP7.
Teng S; Liu G; Li L; Ou J; Yu Y
Biochem Biophys Res Commun; 2022 Jun; 608():128-134. PubMed ID: 35397425
[TBL] [Abstract][Full Text] [Related]
28. CircRNA_0017076 acts as a sponge for miR-185-5p in the control of epithelial-to-mesenchymal transition of tubular epithelial cells during renal interstitial fibrosis.
Zhang F; Zou H; Li X; Liu J; Xie Y; Chen M; Yu J; Wu X; Guo B
Hum Cell; 2023 May; 36(3):1024-1040. PubMed ID: 36828974
[TBL] [Abstract][Full Text] [Related]
29. RGS1 mediates renal interstitial fibrosis through activation of the inflammatory response.
Lu T; Chen S; Xu J
Arch Biochem Biophys; 2023 Dec; 750():109744. PubMed ID: 37696381
[TBL] [Abstract][Full Text] [Related]
30. Silenced miR-21 inhibits renal interstitial fibrosis via targeting ERK1/2 signaling pathway in mice.
Tang CR; Luo SG; Lin X; Wang J; Liu Y
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):110-116. PubMed ID: 31389582
[TBL] [Abstract][Full Text] [Related]
31. GSTA3 Attenuates Renal Interstitial Fibrosis by Inhibiting TGF-Beta-Induced Tubular Epithelial-Mesenchymal Transition and Fibronectin Expression.
Xiao Y; Liu J; Peng Y; Xiong X; Huang L; Yang H; Zhang J; Tao L
PLoS One; 2016; 11(9):e0160855. PubMed ID: 27602565
[TBL] [Abstract][Full Text] [Related]
32. Knockdown of miR-214 Alleviates Renal Interstitial Fibrosis by Targeting the Regulation of the PTEN/PI3K/AKT Signalling Pathway.
Hou D; Wu Q; Wang S; Pang S; Liang H; Lyu H; Zhou L; Wang Q; Hao L
Oxid Med Cell Longev; 2022; 2022():7553928. PubMed ID: 36285295
[TBL] [Abstract][Full Text] [Related]
33. The regulatory peptide apelin: a novel inhibitor of renal interstitial fibrosis.
Wang LY; Diao ZL; Zhang DL; Zheng JF; Zhang QD; Ding JX; Liu WH
Amino Acids; 2014 Dec; 46(12):2693-704. PubMed ID: 25164121
[TBL] [Abstract][Full Text] [Related]
34. Berberine ameliorates renal interstitial fibrosis induced by unilateral ureteral obstruction in rats.
Wang FM; Yang YJ; Ma LL; Tian XJ; He YQ
Nephrology (Carlton); 2014 Sep; 19(9):542-51. PubMed ID: 24754438
[TBL] [Abstract][Full Text] [Related]
35. Silencing of the lncRNA
Zhang B; Zhao C; Hou L; Wu Y
Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1125-F1134. PubMed ID: 33135476
[TBL] [Abstract][Full Text] [Related]
36. Adenosine A2A receptor: a target for regulating renal interstitial fibrosis in obstructive nephropathy.
Xiao H; Shen HY; Liu W; Xiong RP; Li P; Meng G; Yang N; Chen X; Si LY; Zhou YG
PLoS One; 2013; 8(4):e60173. PubMed ID: 23585831
[TBL] [Abstract][Full Text] [Related]
37. Sorafenib ameliorates renal fibrosis through inhibition of TGF-β-induced epithelial-mesenchymal transition.
Jia L; Ma X; Gui B; Ge H; Wang L; Ou Y; Tian L; Chen Z; Duan Z; Han J; Fu R
PLoS One; 2015; 10(2):e0117757. PubMed ID: 25679376
[TBL] [Abstract][Full Text] [Related]
38. Psoralen Alleviates Renal Fibrosis by Attenuating Inflammasome-Dependent NLRP3 Activation and Epithelial-Mesenchymal Transition in a Mouse Unilateral Ureteral Obstruction Model.
Lee TW; Bae E; Kim JH; Jung MH; Park DJ
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685978
[TBL] [Abstract][Full Text] [Related]
39. LncRNA HOTAIR promotes renal interstitial fibrosis by regulating Notch1 pathway via the modulation of miR-124.
Zhou H; Gao L; Yu ZH; Hong SJ; Zhang ZW; Qiu ZZ
Nephrology (Carlton); 2019 Apr; 24(4):472-480. PubMed ID: 29717517
[TBL] [Abstract][Full Text] [Related]
40. Ruxolitinib Alleviates Renal Interstitial Fibrosis in UUO Mice.
Bai Y; Wang W; Yin P; Gao J; Na L; Sun Y; Wang Z; Zhang Z; Zhao C
Int J Biol Sci; 2020; 16(2):194-203. PubMed ID: 31929748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
